In a study using U.S. National Inpatient Sample data from 2016 to 2020, researchers delved into the connection between bariatric metabolic surgery (BMS) and hospital admissions for gastrointestinal (GI) cancers. They found that BMS was linked to a higher risk of gastric and pancreatic cancer hospital admissions but a lower risk of colorectal and liver cancer admissions. The study suggested that the impact of BMS on GI cancer risk is complex, emphasizing the need for further research to fully understand this association and its implications.
Journal Article by Esparham A, Shoar S (…) Modukuru VR et 2 al. in Obes Surg
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.